Login/Sign Up
Gazyva 1000 mg Injection 40 ml
₹327430.1*
MRP ₹399305
18% off
₹339409*
MRP ₹399305
15% CB
₹59896 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
About Gazyva 1000 mg Injection
Gazyva 1000 mg Injection is an anti-cancer medicine used in the treatment of chronic lymphocytic leukaemia (CLL). Chronic lymphocytic leukaemia is a cancer that occurs in the bone marrow and blood. Gazyva 1000 mg Injection is used in combination with chlorambucil for the treatment of CLL, in combination with bendamustine for the treatment of follicular lymphoma in patients who relapsed after or are refractory to a rituximab-containing regimen and in patients with previously untreated stage II bulky, III or IV follicular lymphoma.
Gazyva 1000 mg Injection contains Obinutuzumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells.
Gazyva 1000 mg Injection may cause certain side effects, such as nausea, vomiting, diarrhoea, constipation, fever, decreased platelet count, fatigue, cough, insomnia, injection site reactions and pain at the site of injection. If the side effects bother you, inform your doctor. A trained healthcare professional will administer Gazyva 1000 mg Injection. Hence, do not self-administer.
While taking Gazyva 1000 mg Injection if you experience any allergic reaction, inform your doctor. Before taking the Gazyva 1000 mg Injection, let your doctor know about all your allergic or hypersensitivity reactions to medicines or food. Before receiving this injection, inform your doctor if you have any pre-existing or a history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Gazyva 1000 mg Injection is known to cause fetal B-cell depletion in neonates. Hence, inform your physician if you are pregnant.
Uses of Gazyva 1000 mg Injection
Medicinal Benefits
Gazyva 1000 mg Injection contains Obinutuzumab, which belongs to the class of CD20-directed cytolytic antibodies. It is used in the treatment of chronic lymphocytic leukaemia and follicular lymphoma. This medicine works by binding to the CD20 antibody and causes lysis of B-cell lymphocytes responsible for the multiplication of cancer cells. This causes shrinkage of tumour cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.
Side Effects of Gazyva 1000 mg Injection
Directions for Use
Storage
Drug Warnings
Gazyva 1000 mg Injection should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before receiving this injection, inform your doctor if you have any history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Gazyva 1000 mg Injection may cause remission of active infections, severe skin reactions, reactivation of hepatitis B Virus, increased bilirubin levels, progressive multifocal leukoencephalopathy, tumour lysis syndrome (tumor cells release their contents into the bloodstream), and hypersensitivity reactions in some patients. Hence, careful monitoring should be done during the entire treatment. Gazyva 1000 mg Injection may cause fetal B-cell depletion in infants. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Before nursing, a breastfeeding mother should ask her oncologist whether this medicine is safe for use or not. Gazyva 1000 mg Injection is not recommended for use in children as the safety and efficacy are not established.
Therapeutic Class
Drug Interactions
Drug-Drug Interactions: No interactions found.
Drug-Food Interactions: Avoid alcohol consumption and smoking.
Drug-Disease Interactions: Inform your doctor if you have kidney or liver disease, skin diseases, and infections before receiving Gazyva 1000 mg Injection.
Diet & Lifestyle Advise
Habit Forming
What if I have taken an overdose of Gazyva 1000 mg Injection
Special Advise
Disease/Condition Glossary
Chronic Lymphocytic Leukaemia: It is a type of cancer that occurs in the bone marrow and blood. It increases the number of lymphocytes (a type of white blood cell). The symptoms include fever, enlarged liver, bone or joint pain, shortness of breath, weakness, and bleeding from gums or bruises.
Follicular lymphoma: It is a type of non-Hodgkins lymphoma with slow-growing (chronic) cancer with abnormal growth of B lymphocytes, a type of white blood cells that help fight infection. This results in the buildup of too many B lymphocytes in the blood, lymph nodes, bone marrow, and spleen.
Alcohol
Consult your doctor
It is unknown whether Gazyva 1000 mg Injection interacts with alcohol. Consult your doctor.
Pregnancy
Unsafe
Gazyva 1000 mg Injection is not recommended for use in pregnancy as it may cause fatal B-lymphocyte depletion in your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Gazyva 1000 mg Injection.
Breast Feeding
Caution
If you are breastfeeding, inform your doctor before receiving Gazyva 1000 mg Injection. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Driving
Caution
Gazyva 1000 mg Injection will be administered in the hospital setting. Hence, driving is not recommended.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Gazyva 1000 mg Injection. Gazyva 1000 mg Injection may cause increased bilirubin levels and liver failure. Hence, inform your doctor if you observe any symptoms such as fatigue, yellow discolouration of eyes, and dark coloured urine. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition.
Kidney
Caution
It is not known whether Gazyva 1000 mg Injection can be taken if you have kidney impairment. However, inform your doctor if you have a pre-existing or a history of kidney disease before receiving Gazyva 1000 mg Injection.
Children
Unsafe
Gazyva 1000 mg Injection is not recommended for use in children as the safety and efficacy are not established.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.Prepaid payment required.